From: Vitamin D status in idiopathic Parkinson’s disease: an Egyptian study
Age at onset (years) | Range (40–69) Mean 57.32 ± 6.4 | |
Duration (years) | Range (1–10) Mean 3.42 ± 2.35 | |
Family history of PD, n (%) | 6 (12%) | |
Distribution of starting motor symptoms, n (%) | Bradykinesia | 10 (20%) |
Tremors | 40 (80%) | |
The frequency of non-motor symptoms, n (%) | Constipation | 28 (56%) |
Memory impairment | 15 (30%) | |
Visual problems | 13 (26%) | |
REM sleep behavior disorder | 12 (24%) | |
Depression | 9 (18%) | |
Erectile dysfunction | 3 (6%) | |
Insomnia | 3 (6%) | |
Fatigue | 1 (2%) | |
Impaired olfaction | 1 (2%) | |
Incontinence | 1 (2%) | |
UPDRS scores | Mentation, behavior, and mood | Range (0.0–7) Median 1 |
Activities of daily living | Range (1–33) Median 19 | |
Motor | Range (12–47) Median 28 | |
Modified Hoehn and Yahr staging, n(%) | Stage 1 | 20(40%) |
Stage 1.5 | 11 (22%) | |
Stage 2 | 9 (18%) | |
Stage 2.5 | 4 (8%) | |
Stage 3 | 4 (8%) | |
Stage 4 | 2 (4%) |